Balloon over stent? new study tests Drug-Coated option for heart disease
NCT ID NCT05133921
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether a drug-coated balloon (DCB) can safely treat blocked heart arteries, possibly avoiding the need for a permanent stent. Researchers followed 2487 patients who received the balloon instead of a stent. The goal was to see how well the balloon prevents heart-related deaths, heart attacks, and the need for repeat procedures.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- drug-coated balloon (paclitaxel)
- What this could lead to
- If successful, this could show that a drug-coated balloon is a safe and effective alternative to stents for some people with blocked heart arteries.
- What could go wrong
- This is a single-center, observational study, not a large randomized trial. The balloon can cause complications like artery tearing or sudden blockage, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
2,487 people
The number who actually took part.
- Started
-
Dec 2015
- Finished
-
Dec 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All patients who received PCI with one or more drug-coated balloons (DCB) in the Xijing hospital of the Air Force Medical University from December 1, 2015 to December 1, 2019.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients who received PCI with one or more drug-coated balloons (DCB) 2. Patients who did not received drug-eluting stent implantation Exclusion Criteria: 1\. Currently participating in another trial or participants unable to comply to follow-up
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Angioplasty, balloon are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ling Tao
Xi'an, Shannxi, 710032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A blood test at 50 could flag your risk of five diseases. can an app stop them?
- Can a common gout pill shield hearts after stents?
- Can a simple blood test flag hidden heart risks after stenting?
- Community health workers take on heart disease prevention in cleveland
- Can a heart injection grow new blood vessels?
- Could a cheap vitamin shield the aging brain during heart surgery?